期刊
EXPERT REVIEW OF CLINICAL PHARMACOLOGY
卷 14, 期 9, 页码 1133-1152出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/17512433.2021.1933434
关键词
Psychedelics; randomized controlled trials; LSD; ketamine; psilocybin; causation; blinding; masking; placebo effect
资金
- Health Research Council of New Zealand [18/193]
This study reviewed previous literature on expectancy effects and blinding in psychedelic RCTs and found that these trials might be influenced by de-blinding and expectancy. Current psychedelic RCTs generally do not report pre-trial expectancy or the success rate of blinding procedures. The authors suggest caution in interpreting effect size estimates from existing psychedelic RCTs due to potential confounds related to de-blinding and expectancy.
Introduction: There is increasing interest in the potential for psychedelic drugs such as psilocybin, LSD and ketamine to treat several mental health disorders, with a growing number of randomized controlled trials (RCTs) being conducted to investigate the therapeutic effectiveness of psychedelics. Areas covered: We review previous literature on expectancy effects and blinding in the context of psychedelic RCTs - literature which strongly suggest that psychedelic RCTs might be confounded by de-blinding and expectancy. We conduct systematic reviews of psychedelic RCTs using Medline, PsychInfo and EMBASE (Jan 1990 - Nov 2020) and show that currently reported psychedelic RCTs have generally not reported pre-trial expectancy, nor the success of blinding procedures. Expert opinion: While psychedelic RCTs have generally shown promising results, with large effect sizes reported, we argue that treatment effect sizes in psychedelic RCTs are likely over-estimated due to de-blinding of participants and high levels of response expectancy. We suggest that psychedelic RCTs should routinely measure de-blinding and expectancy. Careful attention should be paid to clinical trial design and the instructions given to participants to allow these confounds to be reduced, estimated and removed from effect size estimates. We urge caution in interpreting effect size estimates from extant psychedelic RCTs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据